RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and ...

In another positive development, Pfizer won a bid in a London court to invalidate two of GSK Plc’s GSK patents relating to its respiratory syncytial virus (RSV) vaccine. Also Read: UK Chooses Pfizer ...

Quebec is rolling out its fall vaccination campaign against respiratory viruses, as contagion levels of COVID-19 and other ...

Illness from RSV is considered an infectious disease, usually leading to an infection of the upper respiratory tract but ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...

In anticipation of the winter season an increased circulation of respiratory viruses is expected with a peak in the coming weeks – and the free fall vaccination campaign will begin soon. Quebec’s ...

The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the ...